Education
About Us
Working with TipRanks
Follow Us
Eli Lilly & Co (IT:1LLY)
:1LLY
Abemaciclib, Letrozole, Anastrozole, Ribociclib, Palbociclib, Fulvestrant, Exemestane, Ly4064809
Breast Neoplasms, Neoplasm Metastasis
Phase III
Not Yet Recruiting
A Study of LY4064809 With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
Sep 12, 2025
Standard Of Care Antiemetic Therapies, Background Chemotherapy, Ly3537021
Neoplasms, Vomiting, Drug-Related Side Effects And Adverse Reactions, Nausea
Phase II
Not Yet Recruiting
A Study to Evaluate LY3537021 for the Treatment of Nausea and Vomiting Caused by Chemotherapy in Adults With Cancer
Sep 05, 2025
Ly3537031
Healthy, Renal Insufficiency, Renal Impairment, End Stage Renal Disease (Esrd)
Phase I
Not Yet Recruiting
A Study of Pharmacokinetics and Safety of LY3537031 in Participants With Normal Renal Function and Participants With Renal Impairment
Sep 03, 2025
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does Eli Lilly & Co (1LLY) have in its pipeline
1LLY is currently developing the following drugs: Abemaciclib, Letrozole, Anastrozole, Ribociclib, Palbociclib, Fulvestrant, Exemestane, Ly4064809, Standard Of Care Antiemetic Therapies, Background Chemotherapy, Ly3537021, Ly3537031. These drug candidates are in various stages of clinical development as the company works toward FDA approval.